VEGFA and persistent fetal circulation syndrome: Treatment with recombinant human VEGF (rhVEGF) in PPHN lamb model increases eNOS expression and activity, preserving PAECs' function, and reverses pulmonary vascular remodeling and RV hypertrophy (70).